PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsVinorelbine tartrate
Vinorelbine tartrate
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
570 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Breast neoplasmsD001943EFO_0003869C503314259521241
Non-small-cell lung carcinomaD002289197854416167
Lung neoplasmsD008175C34.90226947213146
Triple negative breast neoplasmsD064726119111133
Neoplasm metastasisD009362EFO_0009708193114
Brain stem neoplasmsD020295EFO_100176711
Meningeal carcinomatosisD055756EFO_100101211
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
LymphomaD008223C85.98329247
NeoplasmsD009369C8024185340
Hodgkin diseaseD006689C813187128
CarcinomaD002277C80.03107222
Malignant mesotheliomaD000086002293114
MesotheliomaD008654C45293114
Non-hodgkin lymphomaD008228C85.948213
Uterine cervical neoplasmsD00258333712
SarcomaD012509561111
RhabdomyosarcomaD01220827311
Show 31 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Prostatic neoplasmsD011471C614911
Ovarian neoplasmsD010051EFO_0003893C56638
Ovarian epithelial carcinomaD000077216437
B-cell lymphomaD016393155
Large b-cell lymphoma diffuseD016403C83.344
Multiple myelomaD009101C90.0134
Colorectal neoplasmsD015179133
Male breast neoplasmsD018567213
Pancreatic neoplasmsD010190EFO_0003860C25313
LeukemiaD007938C95313
Show 44 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Endometrial neoplasmsD016889EFO_000423022
Adrenocortical carcinomaD01826811
Wilms tumorD009396EFO_000021211
Hematologic neoplasmsD01933711
Peritoneal neoplasmsD01053411
Urinary bladder neoplasmsD001749C6711
Vaginal neoplasmsD014625C5211
Gastrointestinal neoplasmsD005770C26.911
PheochromocytomaD01067311
Skin neoplasmsD012878EFO_0004198C4411
Show 11 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
MethylationD00874511
Multiple primary neoplasmsD00937811
Progression-free survivalD00007798211
ConstipationD003248K59.011
Desmoid tumorsD018222D48.1111
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use